Sigma Planning Corp Sells 1,194 Shares of Kenvue Inc. (NYSE:KVUE)

Sigma Planning Corp cut its holdings in shares of Kenvue Inc. (NYSE:KVUE) by 3.0% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 38,686 shares of the company’s stock after selling 1,194 shares during the quarter. Sigma Planning Corp’s holdings in Kenvue were worth $895,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also bought and sold shares of the business. BNP PARIBAS ASSET MANAGEMENT Holding S.A. grew its holdings in Kenvue by 2,453.9% during the 1st quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. now owns 259,729 shares of the company’s stock valued at $5,574,000 after buying an additional 249,559 shares in the last quarter. HBK Sorce Advisory LLC grew its holdings in shares of Kenvue by 6.7% in the first quarter. HBK Sorce Advisory LLC now owns 81,975 shares of the company’s stock valued at $1,759,000 after purchasing an additional 5,115 shares in the last quarter. Kingsview Wealth Management LLC purchased a new position in shares of Kenvue in the first quarter valued at $253,000. Picton Mahoney Asset Management grew its holdings in shares of Kenvue by 2.4% in the first quarter. Picton Mahoney Asset Management now owns 124,124 shares of the company’s stock valued at $2,663,000 after purchasing an additional 2,924 shares in the last quarter. Finally, Orion Portfolio Solutions LLC grew its holdings in shares of Kenvue by 21.1% in the first quarter. Orion Portfolio Solutions LLC now owns 222,512 shares of the company’s stock valued at $4,775,000 after purchasing an additional 38,713 shares in the last quarter. 97.64% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of research analysts recently weighed in on the stock. UBS Group raised their target price on shares of Kenvue from $20.00 to $22.00 and gave the company a “neutral” rating in a report on Wednesday, August 7th. Piper Sandler raised their target price on shares of Kenvue from $20.00 to $21.00 and gave the company a “neutral” rating in a report on Monday, September 23rd. JPMorgan Chase & Co. raised their target price on shares of Kenvue from $24.00 to $25.00 and gave the company an “overweight” rating in a report on Friday, October 11th. Bank of America lifted their price objective on shares of Kenvue from $24.00 to $27.00 and gave the stock a “buy” rating in a research note on Tuesday, October 22nd. Finally, Royal Bank of Canada lowered shares of Kenvue from an “outperform” rating to a “sector perform” rating and set a $24.00 price objective for the company. in a research note on Tuesday, September 24th. One analyst has rated the stock with a sell rating, seven have assigned a hold rating and four have assigned a buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $22.64.

Kenvue Stock Down 1.3 %

NYSE:KVUE opened at $23.13 on Thursday. The company has a current ratio of 1.00, a quick ratio of 0.69 and a debt-to-equity ratio of 0.66. The stock has a fifty day simple moving average of $22.72 and a 200-day simple moving average of $20.62. The company has a market cap of $44.35 billion, a price-to-earnings ratio of 41.95, a price-to-earnings-growth ratio of 2.15 and a beta of 1.36. Kenvue Inc. has a twelve month low of $17.67 and a twelve month high of $23.95.

Kenvue (NYSE:KVUE) last released its quarterly earnings data on Thursday, November 7th. The company reported $0.28 earnings per share for the quarter, beating the consensus estimate of $0.27 by $0.01. The firm had revenue of $3.90 billion during the quarter, compared to the consensus estimate of $3.92 billion. Kenvue had a return on equity of 21.43% and a net margin of 6.88%. The firm’s quarterly revenue was down .4% on a year-over-year basis. During the same period in the previous year, the company posted $0.31 earnings per share. Analysts anticipate that Kenvue Inc. will post 1.07 EPS for the current year.

Kenvue Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, November 27th. Shareholders of record on Wednesday, November 13th will be issued a $0.205 dividend. The ex-dividend date of this dividend is Wednesday, November 13th. This represents a $0.82 dividend on an annualized basis and a yield of 3.55%. Kenvue’s dividend payout ratio is presently 149.09%.

Kenvue Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.